About British Pharmacopoeia
The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom. It is an annually published collection of quality standards for medicinal substances in the UK, which is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.
Pharmacopoeial standards are publicly available and legally enforceable standards of quality for medicinal products and their constituents. The British Pharmacopoeia is an important statutory component in the control of medicines, which complements and assists the licensing and inspection processes of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). Together with the British National Formulary (BNF), the British Pharmacopoeia defines the UK’s pharmaceutical standards.
Pharmacopoeial standards are compliance requirements; that is, they provide the means for an independent judgement as to the overall quality of an article, and apply throughout the shelf-life of a product. Inclusion of a substance in a pharmacopoeia does not indicate that it is either safe or effective for the treatment of any disease.
British Pharmacopoeia edition
The current edition of the British Pharmacopoeia comprises six volumes, which contain nearly 3,000 monographs for drug substances, excipients, and formulated preparation, together with supporting general notices, appendices (test methods, reagents etc.), and reference spectra, used in the practice of medicine, all comprehensively indexed and cross-referenced for easy reference. Items used exclusively in veterinary medicine in the UK are included in the BP (Veterinary).
Volumes I and II
Infrared Reference Spectra
British Pharmacopoeia (Veterinary)
Volume VI: (CD-ROM version)
British Pharmacopoeia Commission (BPC)
The British Pharmacopoeia Commission (BPC) is an advisory non-departmental public body, sponsored by the Department of Health and Social Care and is subject to a triennial review to provide assurance to the Department and the public that the BPC’s functions are needed and that it is operating effectively. The most recent review was carried out December 2014 – January 2015, the British Pharmacopoeia Commission: triennial review is publicly available.
The BPC is responsible for:
preparing new editions of the British Pharmacopoeia (BP) and British Pharmacopoeia (Veterinary) (BP (Vet))
the selection and publication of British Approved Names (BAN)
providing clear policies and technical advice for the BP
providing advice to the United Kingdom delegation to the European Pharmacopoeia Commission
appointing members to expert advisory groups, panels of experts and working parties
|Headquarters||London, United Kingdom|
First Year B Pharm Notes, Syllabus, Books, PDF Subjectwise/Topicwise